Janus Henderson Group PLC Purchases 53,047 Shares of Bruker Co. (NASDAQ:BRKR)

Janus Henderson Group PLC raised its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 943,236 shares of the medical research company's stock after acquiring an additional 53,047 shares during the quarter. Janus Henderson Group PLC owned 0.62% of Bruker worth $55,295,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in BRKR. Gotham Asset Management LLC grew its holdings in Bruker by 146.7% in the fourth quarter. Gotham Asset Management LLC now owns 106,324 shares of the medical research company's stock valued at $6,233,000 after purchasing an additional 63,231 shares during the last quarter. Expect Equity LLC purchased a new stake in Bruker during the 4th quarter worth about $2,514,000. FORA Capital LLC acquired a new position in Bruker in the 4th quarter valued at about $413,000. Cetera Investment Advisers lifted its holdings in Bruker by 13.8% in the 4th quarter. Cetera Investment Advisers now owns 23,083 shares of the medical research company's stock valued at $1,353,000 after purchasing an additional 2,799 shares in the last quarter. Finally, Braidwell LP purchased a new position in Bruker in the 4th quarter valued at about $20,705,000. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Barclays dropped their target price on Bruker from $50.00 to $46.00 and set an "overweight" rating for the company in a research note on Thursday, May 8th. Guggenheim restated a "buy" rating on shares of Bruker in a report on Monday, February 24th. The Goldman Sachs Group decreased their target price on shares of Bruker from $50.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. UBS Group cut their target price on Bruker from $57.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Finally, Wells Fargo & Company lowered their price target on Bruker from $75.00 to $60.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $60.10.

Bruker Price Performance

NASDAQ BRKR traded down $0.04 on Monday, reaching $37.49. The company's stock had a trading volume of 258,299 shares, compared to its average volume of 1,599,177. Bruker Co. has a twelve month low of $34.10 and a twelve month high of $78.94. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The firm's 50 day moving average is $40.33 and its two-hundred day moving average is $50.41. The stock has a market cap of $5.68 billion, a PE ratio of 49.22, a PEG ratio of 2.16 and a beta of 1.23.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The medical research company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. The company had revenue of $801.40 million for the quarter, compared to analyst estimates of $763.83 million. During the same period in the previous year, the firm earned $0.53 earnings per share. Bruker's revenue for the quarter was up 11.0% compared to the same quarter last year. As a group, sell-side analysts predict that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 27th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.53%. The ex-dividend date of this dividend is Monday, June 16th. Bruker's dividend payout ratio is currently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.